share_log

Canaccord Genuity Initiates Coverage On Hims & Hers Health With Buy Rating, Announces Price Target of $20

Canaccord Genuity Initiates Coverage On Hims & Hers Health With Buy Rating, Announces Price Target of $20

Canaccord Genuity以买入评级启动对他和她的健康状况的保险,宣布目标股价为20美元
Moomoo 24/7 ·  04/10 07:50

Canaccord Genuity analyst Maria Ripps initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Price Target of $20.

Canaccord Genuity分析师玛丽亚·里普斯以买入评级启动了对Hims & Hers Health(纽约证券交易所代码:HIMS)的报道,并宣布目标股价为20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发